APA (7th ed.) Citation

Modi, S., Jacot, W., Yamashita, T., Sohn, J., Vidal, M., Tokunaga, E., . . . Moore, H. C. F. (2022). Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer. New England Journal of Medicine, 387(1), 9. https://doi.org/10.1056/NEJMoa2203690

Chicago Style (17th ed.) Citation

Modi, S., et al. "Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer." New England Journal of Medicine 387, no. 1 (2022): 9. https://doi.org/10.1056/NEJMoa2203690.

MLA (9th ed.) Citation

Modi, S., et al. "Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer." New England Journal of Medicine, vol. 387, no. 1, 2022, p. 9, https://doi.org/10.1056/NEJMoa2203690.